Kaletra and Talipes equinovarus - from FDA reports


Summary

Talipes equinovarus is found among people who take Kaletra, especially for people who are female, 0-1 old , have been taking the drug for < 1 month, also take medication Combivir, and have Drug exposure during pregnancy. This review analyzes which people have Talipes equinovarus with Kaletra. It is created by eHealthMe based on reports of 17,222 people who have side effects when taking Kaletra from FDA , and is updated regularly.

What to expect?

If you take Kaletra and have Talipes equinovarus, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Kaletra and have Talipes equinovarus

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Oct, 24, 2017

17,222 people reported to have side effects when taking Kaletra.
Among them, 86 people (0.5%) have Talipes equinovarus


Number of reports submitted per year:

Could Kaletra cause Talipes equinovarus?

Time on Kaletra when people have Talipes equinovarus *:

  • < 1 month: 42.86 %
  • 1 - 6 months: 35.71 %
  • 6 - 12 months: 21.43 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Talipes equinovarus when taking Kaletra *:

  • female: 64.86 %
  • male: 35.14 %

Age of people who have Talipes equinovarus when taking Kaletra *:

  • 0-1: 57.14 %
  • 2-9: 0.0 %
  • 10-19: 14.29 %
  • 20-29: 14.29 %
  • 30-39: 14.29 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Top conditions involved for these people *:

  • Drug Exposure During Pregnancy (28 people, 32.56%)
  • Multiple Sclerosis (2 people, 2.33%)
  • Bipolar Disorder (2 people, 2.33%)
  • Maternal Exposure During Pregnancy (1 person, 1.16%)
  • Hidradenitis (1 person, 1.16%)

Top co-used drugs for these people *:

  • Combivir (61 people, 70.93%)
  • Truvada (34 people, 39.53%)
  • Efavirenz (11 people, 12.79%)
  • Sustiva (9 people, 10.47%)
  • Viramune (7 people, 8.14%)

Top other side effects for these people *:

  • Foetal Exposure During Pregnancy (36 people, 41.86%)
  • Premature Baby (23 people, 26.74%)
  • Drug Exposure During Pregnancy (20 people, 23.26%)
  • Sepsis (11 people, 12.79%)
  • Dandy-Walker Syndrome (11 people, 12.79%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Talipes equinovarus when taking Kaletra?

Expand the study to include all drugs with the same ingredients

Talipes equinovarus and drugs with ingredients of lopinavir; ritonavir.

Expand the study to include reports from both FDA and eHealthMe

Talipes equinovarus and Kaletra from FDA and eHealthMe reports

Kaletra

Kaletra has active ingredients of lopinavir; ritonavir. It is often used in hiv infection. (latest outcomes from Kaletra 17,412 users)

Talipes equinovarus

Talipes equinovarus (a club foot or clubfoot) has been reported by people with depression, stress and anxiety, drug exposure during pregnancy, epilepsy, hiv infection (latest reports from 2,712 Talipes equinovarus patients).

Browse all side effects of Kaletra

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Talipes equinovarus

Talipes equinovarus

Could your condition cause Talipes equinovarus

Talipes equinovarus

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Kaletra and have Talipes equinovarus.

Questions to the study

More questions >

User reviews to the study

More reviews >